BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 33039422)

  • 1. Early alteration in apparent diffusion coefficient and tumor volume in cervical cancer treated with chemoradiotherapy or radiotherapy: Incremental prognostic value over pretreatment assessments.
    Watanabe Y; Nakamura S; Ichikawa Y; Ii N; Kawamura T; Kondo E; Ikeda T; Nomoto Y; Sakuma H
    Radiother Oncol; 2021 Feb; 155():3-9. PubMed ID: 33039422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diffusion-Weighted Magnetic Resonance Imaging as a Predictor of Outcome in Cervical Cancer After Chemoradiation.
    Ho JC; Allen PK; Bhosale PR; Rauch GM; Fuller CD; Mohamed AS; Frumovitz M; Jhingran A; Klopp AH
    Int J Radiat Oncol Biol Phys; 2017 Mar; 97(3):546-553. PubMed ID: 28011045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of FDG PET metabolic tumour volume versus ADC histogram: prognostic value of tumour treatment response and survival in patients with locally advanced uterine cervical cancer.
    Ueno Y; Lisbona R; Tamada T; Alaref A; Sugimura K; Reinhold C
    Br J Radiol; 2017 Jul; 90(1075):20170035. PubMed ID: 28508679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Can diffusion-weighted magnetic resonance imaging predict tumor recurrence of uterine cervical cancer after concurrent chemoradiotherapy?
    Bae JM; Kim CK; Park JJ; Park BK
    Abdom Radiol (NY); 2016 Aug; 41(8):1604-10. PubMed ID: 27056747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pre-treatment MRI minimum apparent diffusion coefficient value is a potential prognostic imaging biomarker in cervical cancer patients treated with definitive chemoradiation.
    Marconi DG; Fregnani JH; Rossini RR; Netto AK; Lucchesi FR; Tsunoda AT; Kamrava M
    BMC Cancer; 2016 Jul; 16():556. PubMed ID: 27469349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic model based on magnetic resonance imaging, whole-tumour apparent diffusion coefficient values and HPV genotyping for stage IB-IV cervical cancer patients following chemoradiotherapy.
    Lin G; Yang LY; Lin YC; Huang YT; Liu FY; Wang CC; Lu HY; Chiang HJ; Chen YR; Wu RC; Ng KK; Hong JH; Yen TC; Lai CH
    Eur Radiol; 2019 Feb; 29(2):556-565. PubMed ID: 30051142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Whole lesion histogram analysis of apparent diffusion coefficients on MRI predicts disease-free survival in locally advanced squamous cell cervical cancer after radical chemo-radiotherapy.
    Zhao B; Cao K; Li XT; Zhu HT; Sun YS
    BMC Cancer; 2019 Nov; 19(1):1115. PubMed ID: 31729974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predicting tumor recurrence in patients with cervical carcinoma treated with definitive chemoradiotherapy: value of quantitative histogram analysis on diffusion-weighted MR images.
    Erbay G; Onal C; Karadeli E; Guler OC; Arica S; Koc Z
    Acta Radiol; 2017 Apr; 58(4):481-488. PubMed ID: 27445314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of ADC quantification for clinical outcome in uterine cervical cancer treated with concurrent chemoradiotherapy.
    Gu KW; Kim CK; Choi CH; Yoon YC; Park W
    Eur Radiol; 2019 Nov; 29(11):6236-6244. PubMed ID: 30980126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pre-treatment diffusion-weighted MR imaging for predicting tumor recurrence in uterine cervical cancer treated with concurrent chemoradiation: value of histogram analysis of apparent diffusion coefficients.
    Heo SH; Shin SS; Kim JW; Lim HS; Jeong YY; Kang WD; Kim SM; Kang HK
    Korean J Radiol; 2013; 14(4):616-25. PubMed ID: 23901319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment response evaluation using the mean apparent diffusion coefficient in cervical cancer patients treated with definitive chemoradiotherapy.
    Onal C; Erbay G; Guler OC
    J Magn Reson Imaging; 2016 Oct; 44(4):1010-9. PubMed ID: 26919800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pretreatment ADC is not a prognostic factor for local recurrences in head and neck squamous cell carcinoma when clinical T-stage is known.
    Peltenburg B; Driessen JP; Vasmel JE; Pameijer FA; Janssen LM; Terhaard CHJ; de Bree R; Philippens MEP
    Eur Radiol; 2020 Feb; 30(2):1228-1231. PubMed ID: 31529258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Volumetric assessment of apparent diffusion coefficient predicts outcome following chemoradiation for cervical cancer.
    Ho JC; Fang P; Cardenas CE; Mohamed ASR; Fuller CD; Allen PK; Bhosale PR; Frumovitz MM; Jhingran A; Klopp AH
    Radiother Oncol; 2019 Jun; 135():58-64. PubMed ID: 31015171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pretreatment apparent diffusion coefficient of the primary lesion correlates with local failure in head-and-neck cancer treated with chemoradiotherapy or radiotherapy.
    Hatakenaka M; Nakamura K; Yabuuchi H; Shioyama Y; Matsuo Y; Ohnishi K; Sunami S; Kamitani T; Setoguchi T; Yoshiura T; Nakashima T; Nishikawa K; Honda H
    Int J Radiat Oncol Biol Phys; 2011 Oct; 81(2):339-45. PubMed ID: 20832179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of diffusion-weighted imaging as a predictive marker for tumor response in patients undergoing chemoradiation for postoperative recurrences of cervical cancer.
    Chopra S; Verma A; Kundu S; Engineer R; Medhi S; Mahantshetty U; Gupta S; Shrivastava SK
    J Cancer Res Ther; 2012; 8(1):68-73. PubMed ID: 22531517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prognostic value of pretreatment tumor apparent diffusion coefficient values in nasopharyngeal carcinoma.
    Yan DF; Zhang WB; Ke SB; Zhao F; Yan SX; Wang QD; Teng LS
    BMC Cancer; 2017 Oct; 17(1):678. PubMed ID: 29020937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined dynamic contrast enhanced MRI parameter with clinical factors predict the survival of concurrent chemo-radiotherapy in patients with 2018 FIGO IIICr stage cervical cancer.
    Qin F; Pang H; Ma J; Zhao M; Jiang X; Tong R; Yu T; Luo Y; Dong Y
    Eur J Radiol; 2021 Aug; 141():109787. PubMed ID: 34051683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Greater increases in intratumoral apparent diffusion coefficients after chemoradiotherapy predict better overall survival of patients with cervical cancer.
    Holopainen E; Lahtinen O; Könönen M; Anttila M; Vanninen R; Lindgren A
    PLoS One; 2023; 18(5):e0285786. PubMed ID: 37167301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apparent diffusion coefficient for the prediction of tumor response to neoadjuvant chemo-radiotherapy in locally advanced rectal cancer.
    Zhao M; Zhao L; Yang H; Duan Y; Li G
    Radiat Oncol; 2021 Jan; 16(1):17. PubMed ID: 33472660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction of early response to concurrent chemoradiotherapy in cervical cancer: Value of multi-parameter MRI combined with clinical prognostic factors.
    Zheng X; Guo W; Dong J; Qian L
    Magn Reson Imaging; 2020 Oct; 72():159-166. PubMed ID: 32621877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.